Watch On Demand

In this webinar, we describe the process of differentiating human iPSCs into hepatocytes using three distinct media types, each supplemented with specific growth factors and cytokines at key stages of differentiation.

This method provides a relatively straightforward approach to producing mature hepatic cells, enabling the generation of human hepatic organoids from these source cells. This demonstrates a robust method for unlimited organoid development.

We outline a simple, standardised, and robust workflow that utilises Research Use Only (RUO) Growth Factors and Cytokines, combined with high-throughput screening cytometry for phenotypic characterisation and live-cell analysis for monitoring cell growth. This approach simplifies the generation of functional hepatic cells and organoids from iPSCs, facilitating drug discovery, development, and toxicity studies.

Key takeaways:

  • How to differentiate iPSCs into Hepatic lineage cells and organoids
  • Best practices for monitoring differentiation, while confirming lineage and function
  • Dissociation of complex 3D structures into healthy single cells for analysis
  • How Sartorius products can aid in the simplification and development of robust protocols for organoid production A live Q&A session with the speaker follows the presentation.